Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSinclair Pharma Regulatory News (SPH)

  • There is currently no data for SPH

Suspension - Sinclair Pharma Plc

5 Nov 2018 07:30

RNS Number : 2398G
AIM
05 November 2018
 

 

 

 

NOTICE

 

05/11/2018 7:30am

 

TEMPORARY SUSPENSION OF TRADING ON AIM

 

SINCLAIR PHARMA PLC

 

At the request of the Company trading on AIM for the under-mentioned securities has been temporarily suspended from 05/11/2018 7:30am, pending an announcement.

 

ORDINARY SHARES OF 1P EACH, FULLY PAID (3385674) (GB0033856740)

 

If you have any queries relating to the above, please contact the company's nominated adviser on +44 (0)20 7418 8900

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
EXCELLFBVFFFFBD
Date   Source Headline
17th Oct 20187:00 amRNSDisclosure under Rule 2.10(c)
17th Oct 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
16th Oct 20183:20 pmRNSForm 8.3 - Sinclair Pharma plc
16th Oct 20183:11 pmRNSForm 8.3 - Sinclair Pharma PLC
16th Oct 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
15th Oct 20183:22 pmRNSForm 8.3 - Sinclair Pharma plc
15th Oct 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
12th Oct 20183:27 pmRNSForm 8.3 - Sinclair Pharma plc
12th Oct 20182:57 pmBUSForm 8.3 - Sinclair Pharma plc
12th Oct 20189:04 amBUSForm 8.3 - Sinclair Pharma plc
12th Oct 20188:51 amBUSForm 8.3 - Sinclair Pharma
11th Oct 20183:16 pmRNSForm 8.3 - Sinclair Pharma plc
11th Oct 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
10th Oct 20183:14 pmRNSForm 8.3 - Sinclair Pharma plc
10th Oct 20181:47 pmRNSForm 8.3 - Sinclair Pharma Plc
10th Oct 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
9th Oct 20185:28 pmRNSForm 8.3 - Sinclair Pharma plc
9th Oct 20182:18 pmRNSForm 8.3 - Sinclair Pharma Plc
9th Oct 20181:02 pmRNSHolding(s) in Company
9th Oct 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
9th Oct 20189:47 amRNSForm 8.3 - SINCLAIR PHARMA PLC
8th Oct 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
5th Oct 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma plc
4th Oct 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
3rd Oct 20183:33 pmBUSForm 8.3 - Sinclair Pharma plc
3rd Oct 201812:07 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
3rd Oct 20189:22 amRNSForm 8.3 - SINCLAIR PHARMA PLC
2nd Oct 20183:31 pmBUSForm 8.3 - Sinclair Pharma plc
2nd Oct 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
2nd Oct 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
1st Oct 20184:49 pmBUSForm 8.3 - Sinclair Pharma plc
1st Oct 20184:27 pmRNSPosting of Scheme Document
1st Oct 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma PLC
1st Oct 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
28th Sep 20186:00 pmBUSForm 8.3 - Sinclair Pharma plc
28th Sep 20182:04 pmRNSForm 8.3 - Sinclair Pharma Plc
28th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
28th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
27th Sep 20183:30 pmBUSForm 8.3 - Sinclair Pharma plc
27th Sep 20182:20 pmRNSForm 8.3 - Sinclair Pharma Plc
27th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
27th Sep 201810:57 amRNSForm 8.3 - SINCLAIR PHARMA PLC
27th Sep 20187:00 amRNSInterim Results
27th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
26th Sep 20182:25 pmBUSForm 8.3 - Sinclair Pharma plc
26th Sep 20182:09 pmRNSForm 8.3 - Sinclair Pharma PLC
26th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
25th Sep 20182:46 pmBUSForm 8.3 - Sinclair Pharma plc
25th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
25th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.